K. N. Roy Chengappa, MD

Metformin for Insulin Resistance in TRBD

February 1, 2022

Therapeutic options for treatment-resistant bipolar depression (TRBD) are limited. Since insulin resistance (IR) increases risk of TRBD, this study examined if the insulin sensitizer metformin reversed IR and improved...

Cynthia V. Calkin, K. N. Roy Chengappa, Kathleen Cairns, et al

Original Research

Benefits of Ashwagandha for Schizophrenia

July 10, 2018

Read a study on how a extract of Ashwagandha (Withania somnifera), when added to antipsychotic medications to patients with schizophrenia.

K. N. Roy Chengappa, Jaspreet S. Brar, Jessica M. Gannon, et al

Original Research

Reducing Anticholinergic Burden in SMI

November 21, 2017

Anticholinergic medications, which are often taken by individuals with schizophrenia to counter antipsychotic-induced extrapyramidal symptoms, can themselves cause burdensome side effects. Read this article to learn the results of...

Ana M. Lupu, Kimberly Clinebell, Jessica M. Gannon, et al

Letter to the Editor

Dr Chengappa and Colleagues Reply

May 27, 2015

K. N. Roy Chengappa, Kenneth A. Perkins, Jaspreet S. Brar, et al

Original Research

Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

June 10, 2014

K. N. Roy Chengappa, Kenneth A. Perkins, Jaspreet S. Brar, et al

Original Research

Randomized Placebo-Controlled Adjunctive Study of an Extract of Withania somnifera for Cognitive Dysfunction in Bipolar Disorder

November 15, 2013

K. N. Roy Chengappa, Christopher R. Bowie, Patricia J. Schlicht, et al

Letter to the Editor

Recurrent Episodes of Hypothermia With Psychiatric Medications: An Unsuspected Case of Primary Adrenal Insufficiency

February 9, 2012

Abdulkader Alam, Jodie Bryk, K. N. Roy Chengappa

Original Research

Adjunctive Topiramate Therapy in Patients Receiving a Mood Stabilizer for Bipolar I Disorder: A Randomized, Placebo-Controlled Trial

November 15, 2006

K. N. Roy Chengappa, Lesley K. Schwarzman, Joseph F. Hulihan, et al

Article

Introduction: Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders

June 1, 2003

K. N. Roy Chengappa

Original Research

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

July 1, 2001

K. N. Roy Chengappa, Radha K. Kambhampati, Kenneth Perkins, et al

Letter to the Editor

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

September 30, 2000

Joseph Levine, K. N. Roy Chengappa, Haranath Parepally

Article

Use of Electroconvulsive Therapy in a State Hospital: A 10-Year Review

July 31, 2000

Alfred P. Sylvester, Benoit H. Mulsant, K. N. Roy Chengappa, et al

Metformin for Insulin Resistance in TRBD

Benefits of Ashwagandha for Schizophrenia

Reducing Anticholinergic Burden in SMI

Dr Chengappa and Colleagues Reply

Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Randomized Placebo-Controlled Adjunctive Study of an Extract of Withania somnifera for Cognitive Dysfunction in Bipolar Disorder

Recurrent Episodes of Hypothermia With Psychiatric Medications: An Unsuspected Case of Primary Adrenal Insufficiency

Adjunctive Topiramate Therapy in Patients Receiving a Mood Stabilizer for Bipolar I Disorder: A Randomized, Placebo-Controlled Trial

Introduction: Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

Use of Electroconvulsive Therapy in a State Hospital: A 10-Year Review

ELSEWHERE:

FOLLOW US:

K. N. Roy Chengappa, MD

Metformin for Insulin Resistance in TRBD

Benefits of Ashwagandha for Schizophrenia

Reducing Anticholinergic Burden in SMI

Dr Chengappa and Colleagues Reply

Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Randomized Placebo-Controlled Adjunctive Study of an Extract of Withania somnifera for Cognitive Dysfunction in Bipolar Disorder

Recurrent Episodes of Hypothermia With Psychiatric Medications: An Unsuspected Case of Primary Adrenal Insufficiency

Adjunctive Topiramate Therapy in Patients Receiving a Mood Stabilizer for Bipolar I Disorder: A Randomized, Placebo-Controlled Trial

Introduction: Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

Use of Electroconvulsive Therapy in a State Hospital: A 10-Year Review

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles